Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1997 Oct 15:825:23-9.
doi: 10.1111/j.1749-6632.1997.tb48411.x.

Adenosine A1 receptor agonists as clinically viable agents for treatment of ischemic brain disorders

N Bischofberger  1 , K A Jacobson, D K von Lubitz
Affiliations
Review

Adenosine A1 receptor agonists as clinically viable agents for treatment of ischemic brain disorders

N Bischofberger et al. Ann N Y Acad Sci. .
No abstract available

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Chemical structure of the A1 agonists CPA and ADAC and the A1 antagonist CPX.
FIGURE 2
FIGURE 2
Effect of ADAC administration (single dose of 100 µg/kg) at 6 hr and 12 hr postischemia on neuronal survival following 5 min ischemia in gerbils. ap < 0.05. Bars: SEM.
FIGURE 3
FIGURE 3
10 day survival of gerbils following 10 min ischemia after chronic administration of ADAC (60 days) at different doses.
See this image and copyright information in PMC

References

    1. Rudolphi KA, Schubert P, Parkinson FE, Fredholm BB. Cerebrovasc. Brain Metab. Rev. 1992;4:346–369. - PubMed
    1. Rudolphi KA, Schubert P, Parkinson FE, Fredholm BB. Trends Pharmacol. Sci. 1992;13(12):439–445. - PubMed
    1. Miller LP, Hsu C. J. Neurotrauma. 1992;9(Suppl. 2):S563–S577. - PubMed
    1. von Lubitz DKJE, Carter MF, Beenhakker M, Lin RC-S, Jacobson KA. Adenosine: a prototherapeutic concept in neurodegeneration. In: Trembly B, Slikker W Jr, editors. Neuroprotective Agents: Clinical and Experimental Aspects. Vol. 765. Ann. N. Y. Acad. Sci.; 1995. pp. 163–178. - PMC - PubMed
    1. Schubert P, Kreutzberg GW. Neuroprotective mechanisms of endogenous adenosine action and pharmacological implications. In: Krieglstein J, Oberpichler H, editors. Pharmacology of Cerebral Ischemia. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 1990. p. 417.

LinkOut - more resources